Amphastar Pharmaceuticals is the 42nd drugmaker to announce 340B contract pharmacy restrictions and the fifth to utilize Truzo.

Amphastar Pharmaceuticals 42nd Drugmaker to Place 340B Contract Pharmacy Restrictions, 5th to Use Truzo

May 7, 2026 Shannon Young, Associate Editor/Senior Writer 340B Report Views

A California-based drugmaker this week announced new contract pharmacy restrictions for covered entities looking to purchase a low blood sugar [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!